Literature DB >> 11146003

Mitochondria deficient in complex I activity are depolarized by hydrogen peroxide in nerve terminals: relevance to Parkinson's disease.

C Chinopoulos1, V Adam-Vizi.   

Abstract

Deficiency of complex I in the respiratory chain and oxidative stress induced by hydrogen peroxide occur simultaneously in dopaminergic neurones in Parkinson's disease. Here we demonstrate that the membrane potential of in situ mitochondria (Delta Psi m), as measured by the fluorescence change of JC-l (5,5',6,6'-tetrachloro-1,1,3,3'-tetraethylbezimidazolyl-carbocyani ne iodide), collapses when isolated nerve terminals are exposed to hydrogen peroxide (H(2)O(2), 100 and 500 microM) in combination with the inhibition of complex I by rotenone (5 nM-1 microM). H(2)O(2) reduced the activity of complex I by 17%, and the effect of H(2)O(2) and rotenone on the enzyme was found to be additive. A decrease in Delta Psi m induced by H(2)O(2) was significant when the activity of complex I was reduced to a similar extent as found in Parkinson's disease (26%). The loss of Delta Psi m observed in the combined presence of complex I deficiency and H(2)O(2) indicates that when complex I is partially inhibited, mitochondria in nerve terminals become more vulnerable to H(2)O(2)-induced oxidative stress. This mechanism could be crucial in the development of bioenergetic failure in Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11146003     DOI: 10.1046/j.1471-4159.2001.00060.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  21 in total

Review 1.  Oxidative stress in phenylketonuria: what is the evidence?

Authors:  Graziela S Ribas; Angela Sitta; Moacir Wajner; Carmen R Vargas
Journal:  Cell Mol Neurobiol       Date:  2011-04-23       Impact factor: 5.046

Review 2.  Alpha-ketoglutarate dehydrogenase: a target and generator of oxidative stress.

Authors:  Laszlo Tretter; Vera Adam-Vizi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-12-29       Impact factor: 6.237

3.  Diabetes-induced abnormalities of mitochondrial function in rat brain cortex: the effect of n-3 fatty acid diet.

Authors:  Maria Chomova; Maria Balazova; Jana Muchova
Journal:  Mol Cell Biochem       Date:  2017-05-19       Impact factor: 3.396

4.  An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage.

Authors:  Todd B Sherer; Ranjita Betarbet; Amy K Stout; Serena Lund; Melisa Baptista; Alexander V Panov; Mark R Cookson; J Timothy Greenamyre
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

5.  Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP+, or paraquat.

Authors:  Won-Seok Choi; Shane E Kruse; Richard D Palmiter; Zhengui Xia
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-23       Impact factor: 11.205

Review 6.  AIF, reactive oxygen species, and neurodegeneration: a "complex" problem.

Authors:  Brian M Polster
Journal:  Neurochem Int       Date:  2012-12-12       Impact factor: 3.921

Review 7.  The ubiquitin-proteasome system in spongiform degenerative disorders.

Authors:  Brandi R Whatley; Lian Li; Lih-Shen Chin
Journal:  Biochim Biophys Acta       Date:  2008-08-23

8.  Inhibition of the mitochondrial respiratory chain by alanine in rat cerebral cortex.

Authors:  Virginia C Rech; Luciane R Feksa; Carlos S Dutra-Filho; Angela T S Wyse; Moacir Wajner; Clovis M D Wannmacher
Journal:  Metab Brain Dis       Date:  2002-09       Impact factor: 3.584

9.  Anti-convulsant effect and mechanism of Astragalus mongholicus extract in vitro and in vivo: protection against oxidative damage and mitochondrial dysfunction.

Authors:  Jalsrai Aldarmaa; Zhongbo Liu; Jiangang Long; Xiaoyan Mo; Jiangang Ma; Jiankang Liu
Journal:  Neurochem Res       Date:  2009-07-04       Impact factor: 3.996

10.  Activation of Retinoid X Receptor increases dopamine cell survival in models for Parkinson's disease.

Authors:  Stina Friling; Maria Bergsland; Susanna Kjellander
Journal:  BMC Neurosci       Date:  2009-12-11       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.